OpenProtein.AI, a leader in AI-powered protein engineering software, today announced an expansion of its partnership with Boehringer Ingelheim to co-develop specialized antibody discovery and ...
Collaboration aims to discover and develop antibodies against multiple therapeutic targets designated by Merck -- Infinimmune's platform combines large-scale human immune repertoire single cell ...
A new integrated service allows Tamarind Bio’s platform users to validate affinity and specificity of computationally designed binder predictions through A-Alpha Bio’s AlphaSeq platform.SAN FRANCISCO ...
SAN FRANCISCO and ROSEMONT, Ill., March 23, 2026 /PRNewswire/ -- Biocare Medical, a global leader in immunohistochemistry (IHC) reagents and diagnostic assay solutions, and Proteintech, a global ...
R&D software developer Dotmatics is rolling out a platform for discovering and developing therapeutic antibodies and proteins. It’s the first part of what the company describes will grow to become a ...
Creative Biolabs, a global leader in antibody engineering, today announced its optimization of ADCC and Fc-mediated effector functions. SHIRLEY, NY, UNITED STATES ...
A Same-day Sequence Optimization Service to Elevate Antibody Expression Levels by RevolKa’s advanced AI Protein Engineering EngineSENDAI, Japan--(BUSINESS WIRE)--RevolKa Ltd. (RevolKa), a ...
Antibody engineering enables the generation of novel and diverse antibody constructs. The development of therapeutic antibodies is highly dependent on antibody engineering, whether for the generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results